{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:48:52Z","timestamp":1760100532754},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,10,13]],"date-time":"2012-10-13T00:00:00Z","timestamp":1350086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s10753-012-9551-5","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T13:05:57Z","timestamp":1350479157000},"page":"337-345","source":"Crossref","is-referenced-by-count":12,"title":["Silencing of miR155 Promotes the Production of Inflammatory Mediators in Guillain\u2013Barr\u00e9 Syndrome In Vitro"],"prefix":"10.1007","volume":"36","author":[{"given":"Yu-Zhong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun-Gang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Guang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Lei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Xia","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,13]]},"reference":[{"key":"9551_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","volume":"100","author":"RA Hughes","year":"1999","unstructured":"Hughes, R.A., R.D. Hadden, N.A. Gregson, and K.J. Smith. 1999. Pathogenesis of Guillain\u2013Barre syndrome. Journal of Neuroimmunology 100: 74\u201397.","journal-title":"Journal of Neuroimmunology"},{"key":"9551_CR2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.51","volume":"68","author":"KK Nyati","year":"2011","unstructured":"Nyati, K.K., K.N. Prasad, A. Rizwan, A. Verma, and V.K. Paliwal. 2011. TH1 and TH2 response to Campylobacter jejuni antigen in Guillain\u2013Barre syndrome. Archives of Neurology 68: 445\u2013452.","journal-title":"Archives of Neurology"},{"key":"9551_CR3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","volume":"7","author":"PA Doorn van","year":"2008","unstructured":"van Doorn, P.A., L. Ruts, and B.C. Jacobs. 2008. Clinical features, pathogenesis, and treatment of Guillain\u2013Barre syndrome. Lancet Neurology 7: 939\u2013950.","journal-title":"Lancet Neurology"},{"key":"9551_CR4","doi-asserted-by":"crossref","unstructured":"Hughes, R.A., A.V. Swan and P.A. van Doorn. 2010. Intravenous immunoglobulin for Guillain\u2013Barre syndrome. The Cochrane Database of Systematic Reviews CD002063.","DOI":"10.1002\/14651858.CD002063.pub4"},{"issue":"Suppl 1","key":"9551_CR5","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1007\/s10875-010-9407-4","volume":"30","author":"PA Doorn van","year":"2010","unstructured":"van Doorn, P.A., K. Kuitwaard, C. Walgaard, R. van Koningsveld, L. Ruts, and B.C. Jacobs. 2010. IVIG treatment and prognosis in Guillain\u2013Barre syndrome. Journal of Clinical Immunology 30(Suppl 1): S74\u2013S78.","journal-title":"Journal of Clinical Immunology"},{"key":"9551_CR6","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1212\/01.wnl.0000310983.38724.d4","volume":"70","author":"A Alshekhlee","year":"2008","unstructured":"Alshekhlee, A., Z. Hussain, B. Sultan, and B. Katirji. 2008. Guillain\u2013Barre syndrome: incidence and mortality rates in US hospitals. Neurology 70: 1608\u20131613.","journal-title":"Neurology"},{"key":"9551_CR7","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","volume":"125","author":"HJ Willison","year":"2002","unstructured":"Willison, H.J., and N. Yuki. 2002. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125: 2591\u20132625.","journal-title":"Brain"},{"key":"9551_CR8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","volume":"39","author":"CE Hafer-Macko","year":"1996","unstructured":"Hafer-Macko, C.E., K.A. Sheikh, C.Y. Li, T.W. Ho, D.R. Cornblath, G.M. McKhann, A.K. Asbury, and J.W. Griffin. 1996. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Annals of Neurology 39: 625\u2013635.","journal-title":"Annals of Neurology"},{"key":"9551_CR9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee, R.C., R.L. Feinbaum, and V. Ambros. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843\u2013854.","journal-title":"Cell"},{"key":"9551_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nri2957","volume":"11","author":"LA O'Neill","year":"2011","unstructured":"O'Neill, L.A., F.J. Sheedy, and C.E. McCoy. 2011. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nature Reviews Immunology 11: 163\u2013175.","journal-title":"Nature Reviews Immunology"},{"key":"9551_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4110\/in.2011.11.1.11","volume":"11","author":"TY Ha","year":"2011","unstructured":"Ha, T.Y. 2011. The role of microRNAs in regulatory T cells and in the immune response. Immune Network 11: 11\u201341.","journal-title":"Immune Network"},{"key":"9551_CR12","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1128\/MCB.17.3.1490","volume":"17","author":"W Tam","year":"1997","unstructured":"Tam, W., D. Ben-Yehuda, and W.S. Hayward. 1997. bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Molecular and Cellular Biology 17: 1490\u20131502.","journal-title":"Molecular and Cellular Biology"},{"key":"9551_CR13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.1141229","volume":"316","author":"TH Thai","year":"2007","unstructured":"Thai, T.H., D.P. Calado, S. Casola, K.M. Ansel, C. Xiao, Y. Xue, A. Murphy, D. Frendewey, D. Valenzuela, J.L. Kutok, M. Schmidt-Supprian, N. Rajewsky, G. Yancopoulos, A. Rao, and K. Rajewsky. 2007. Regulation of the germinal center response by microRNA-155. Science 316: 604\u2013608.","journal-title":"Science"},{"key":"9551_CR14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","volume":"316","author":"A Rodriguez","year":"2007","unstructured":"Rodriguez, A., E. Vigorito, S. Clare, M.V. Warren, P. Couttet, D.R. Soond, S. van Dongen, R.J. Grocock, P.P. Das, E.A. Miska, D. Vetrie, K. Okkenhaug, A.J. Enright, G. Dougan, M. Turner, and A. Bradley. 2007. Requirement of bic\/microRNA-155 for normal immune function. Science 316: 608\u2013611.","journal-title":"Science"},{"key":"9551_CR15","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov, K.D., M.P. Boldin, K.J. Chang, and D. Baltimore. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America 103: 12481\u201312486.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9551_CR16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2007.10.009","volume":"27","author":"E Vigorito","year":"2007","unstructured":"Vigorito, E., K.L. Perks, C. Abreu-Goodger, S. Bunting, Z. Xiang, S. Kohlhaas, P.P. Das, E.A. Miska, A. Rodriguez, A. Bradley, K.G. Smith, C. Rada, A.J. Enright, K.M. Toellner, I.C. Maclennan, and M. Turner. 2007. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27: 847\u2013859.","journal-title":"Immunity"},{"key":"9551_CR17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000328200","volume":"19","author":"YZ Wang","year":"2012","unstructured":"Wang, Y.Z., Q.H. Liang, H. Ramkalawan, Y.L. Wang, Y.F. Yang, W.B. Zhou, F.F. Tian, J. Li, and H. Yang. 2012. Expression of Toll-like receptors 2, 4 and 9 in patients with Guillain\u2013Barre syndrome. Neuroimmunomodulation 19: 60\u201368.","journal-title":"Neuroimmunomodulation"},{"key":"9551_CR18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","volume":"326","author":"FG Meche van der","year":"1992","unstructured":"van der Meche, F.G., and P.I. Schmitz. 1992. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain\u2013Barre syndrome. Dutch Guillain-Barre Study Group. The New England Journal of Medicine 326: 1123\u20131129.","journal-title":"The New England Journal of Medicine"},{"key":"9551_CR19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2010.09.009","volume":"33","author":"RM O'Connell","year":"2010","unstructured":"O'Connell, R.M., D. Kahn, W.S. Gibson, J.L. Round, R.L. Scholz, A.A. Chaudhuri, M.E. Kahn, D.S. Rao, and D. Baltimore. 2010. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33: 607\u2013619.","journal-title":"Immunity"},{"key":"9551_CR20","first-page":"663","volume":"5","author":"D Ray","year":"1990","unstructured":"Ray, D., S. Culine, A. Tavitain, and F. Moreau-Gachelin. 1990. The human homologue of the putative proto-oncogene Spi-1: characterization and expression in tumors. Oncogene 5: 663\u2013668.","journal-title":"Oncogene"},{"key":"9551_CR21","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1093\/emboj\/17.15.4456","volume":"17","author":"RP DeKoter","year":"1998","unstructured":"DeKoter, R.P., J.C. Walsh, and H. Singh. 1998. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte\/macrophage progenitors. The EMBO Journal 17: 4456\u20134468.","journal-title":"The EMBO Journal"},{"key":"9551_CR22","doi-asserted-by":"crossref","first-page":"16334","DOI":"10.1074\/jbc.M109.011601","volume":"284","author":"RT Martinez-Nunez","year":"2009","unstructured":"Martinez-Nunez, R.T., F. Louafi, P.S. Friedmann, and T. Sanchez-Elsner. 2009. MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). The Journal of Biological Chemistry 284: 16334\u201316342.","journal-title":"The Journal of Biological Chemistry"},{"key":"9551_CR23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1365-2249.2001.01424.x","volume":"123","author":"C Ekerfelt","year":"2001","unstructured":"Ekerfelt, C., C. Dahle, R. Weissert, M. Kvarnstrom, T. Olsson, and J. Ernerudh. 2001. Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis. Clinical and Experimental Immunology 123: 112\u2013118.","journal-title":"Clinical and Experimental Immunology"},{"key":"9551_CR24","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.biocel.2006.05.007","volume":"38","author":"K Bhatheja","year":"2006","unstructured":"Bhatheja, K., and J. Field. 2006. Schwann cells: origins and role in axonal maintenance and regeneration. The International Journal of Biochemistry & Cell Biology 38: 1995\u20131999.","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"9551_CR25","doi-asserted-by":"crossref","first-page":"e12450","DOI":"10.1371\/journal.pone.0012450","volume":"5","author":"J Bremer","year":"2010","unstructured":"Bremer, J., T. O'Connor, C. Tiberi, H. Rehrauer, J. Weis, and A. Aguzzi. 2010. Ablation of Dicer from murine Schwann cells increases their proliferation while blocking myelination. PloS One 5: e12450.","journal-title":"PloS One"},{"key":"9551_CR26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuron.2010.01.027","volume":"65","author":"JC Dugas","year":"2010","unstructured":"Dugas, J.C., T.L. Cuellar, A. Scholze, B. Ason, A. Ibrahim, B. Emery, J.L. Zamanian, L.C. Foo, M.T. McManus, and B.A. Barres. 2010. Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination. Neuron 65: 597\u2013611.","journal-title":"Neuron"},{"key":"9551_CR27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/MCB.15.1.59","volume":"15","author":"Y Kominato","year":"1995","unstructured":"Kominato, Y., D. Galson, W.R. Waterman, A.C. Webb, and P.E. Auron. 1995. Monocyte expression of the human prointerleukin 1 beta gene (IL1B) is dependent on promoter sequences which bind the hematopoietic transcription factor Spi-1\/PU.1. Molecular and Cellular Biology 15: 58\u201368.","journal-title":"Molecular and Cellular Biology"},{"key":"9551_CR28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2009.10.003","volume":"125","author":"P Fasanaro","year":"2010","unstructured":"Fasanaro, P., S. Greco, M. Ivan, M.C. Capogrossi, and F. Martelli. 2010. microRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacology and Therapeutics 125: 92\u2013104.","journal-title":"Pharmacology and Therapeutics"},{"key":"9551_CR29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(97)00238-5","volume":"84","author":"J Zhu","year":"1998","unstructured":"Zhu, J., E. Mix, and H. Link. 1998. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain\u2013Barre syndrome. Journal of Neuroimmunology 84: 40\u201352.","journal-title":"Journal of Neuroimmunology"},{"key":"9551_CR30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2249.1994.tb06142.x","volume":"98","author":"J Zhu","year":"1994","unstructured":"Zhu, J., E. Mix, T. Olsson, and H. Link. 1994. Cellular mRNA expression of interferon-gamma, IL-4 and transforming growth factor-beta (TGF-beta) by rat mononuclear cells stimulated with peripheral nerve myelin antigens in experimental allergic neuritis. Clinical and Experimental Immunology 98: 306\u2013312.","journal-title":"Clinical and Experimental Immunology"},{"key":"9551_CR31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbrc.2010.10.042","volume":"402","author":"RK Kutty","year":"2010","unstructured":"Kutty, R.K., C.N. Nagineni, W. Samuel, C. Vijayasarathy, J.J. Hooks, and T.M. Redmond. 2010. Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK\/STAT pathway. Biochemical and Biophysical Research Communications 402: 390\u2013395.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9551_CR32","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1073\/pnas.0811073106","volume":"106","author":"M Ceppi","year":"2009","unstructured":"Ceppi, M., P.M. Pereira, I. Dunand-Sauthier, E. Barras, W. Reith, M.A. Santos, and P. Pierre. 2009. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 106: 2735\u20132740.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9551_CR33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/eji.200939381","volume":"40","author":"A Banerjee","year":"2010","unstructured":"Banerjee, A., F. Schambach, C.S. DeJong, S.M. Hammond, and S.L. Reiner. 2010. Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells. European Journal of Immunology 40: 225\u2013231.","journal-title":"European Journal of Immunology"},{"key":"9551_CR34","doi-asserted-by":"crossref","first-page":"10436","DOI":"10.1128\/JVI.00752-08","volume":"82","author":"F Lu","year":"2008","unstructured":"Lu, F., A. Weidmer, C.G. Liu, S. Volinia, C.M. Croce, and P.M. Lieberman. 2008. Epstein\u2013Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. Journal of Virology 82: 10436\u201310443.","journal-title":"Journal of Virology"},{"key":"9551_CR35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/08820139.2011.604864","volume":"41","author":"YZ Wang","year":"2012","unstructured":"Wang, Y.Z., Q.H. Liang, H. Ramkalawan, W. Zhang, W.B. Zhou, B. Xiao, F.F. Tian, H. Yang, J. Li, Y. Zhang, and N.A. Xu. 2012. Inactivation of TLR9 by a suppressive oligodeoxynucleotides can ameliorate the clinical signs of EAN. Immunological Investigations 41: 171\u2013182.","journal-title":"Immunological Investigations"},{"key":"9551_CR36","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.24436","volume":"60","author":"Y Tang","year":"2009","unstructured":"Tang, Y., X. Luo, H. Cui, X. Ni, M. Yuan, Y. Guo, X. Huang, H. Zhou, N. de Vries, P.P. Tak, S. Chen, and N. Shen. 2009. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis and Rheumatism 60: 1065\u20131075.","journal-title":"Arthritis and Rheumatism"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-012-9551-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-012-9551-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-012-9551-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T15:19:21Z","timestamp":1562253561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-012-9551-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,13]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["9551"],"URL":"https:\/\/doi.org\/10.1007\/s10753-012-9551-5","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,13]]}}}